Cargando…
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
SIMPLE SUMMARY: Anal squamous cell carcinoma (SCC) is a rare cancer often caused by infection with high-risk human papillomavirus (HPV). Immune checkpoint blockade (ICB) targeting PD-1 or PD-L1 is successfully used for the treatment of other cancers as melanoma and lung cancer and might be an option...
Autores principales: | Wessely, Anja, Heppt, Markus V., Kammerbauer, Claudia, Steeb, Theresa, Kirchner, Thomas, Flaig, Michael J., French, Lars E., Berking, Carola, Schmoeckel, Elisa, Reinholz, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564961/ https://www.ncbi.nlm.nih.gov/pubmed/32899762 http://dx.doi.org/10.3390/cancers12092516 |
Ejemplares similares
-
How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance
por: Wessely, Anja, et al.
Publicado: (2021) -
Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?
por: Wessely, Anja, et al.
Publicado: (2020) -
The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments
por: Steeb, Theresa, et al.
Publicado: (2020) -
Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trials
por: Steeb, Theresa, et al.
Publicado: (2022) -
eImmunonkologie: Development and Launch of a Virtual Education Platform for the Immunotherapy of Cutaneous Neoplasms
por: Kaufmann, Matthias D., et al.
Publicado: (2022)